AAAAAA
Results: 1-25/49
Authors:
Bode, JG
Ludwig, S
Freitas, CAC
Schaper, F
Ruhl, M
Melmed, S
Heinrich, PC
Haussinger, D
Citation: Jg. Bode et al., The MKK6/p38 mitogen-activated protein kinase pathway is capable of inducing SOCS3 gene expression and inhibits IL-6-induced transcription, BIOL CHEM, 382(10), 2001, pp. 1447-1453
Authors:
Klibanski, A
Ho, K
Freda, PU
Clemmons, DR
Barkan, AL
Kleinberg, DL
Trainer, PJ
Swearingen, B
Molitch, ME
Wass, JAH
Thorner, MO
Melmed, S
Strasburger, CJ
Frohman, LA
Citation: A. Klibanski et al., State-of-the-art strategies for the diagnosis and management of acromegaly, ENDOCRINOLO, 11(3), 2001, pp. 223-232
Authors:
Yu, R
Melmed, S
Citation: R. Yu et S. Melmed, Oncogene activation in pituitary tumors, BRAIN PATH, 11(3), 2001, pp. 328-341
Authors:
Ben-Shlomo, A
Melmed, S
Citation: A. Ben-shlomo et S. Melmed, Acromegaly, END METAB C, 30(3), 2001, pp. 565
Authors:
Melmed, S
Citation: S. Melmed, Citation for the 2001 Robert H. Williams Distinguished Leadership Award ofthe Endocrine Society to Dr. Jesse Roth, MOL ENDOCR, 15(8), 2001, pp. 1458-1459
Authors:
Wang, ZY
Yu, R
Melmed, S
Citation: Zy. Wang et al., Mice lacking pituitary tumor transforming gene show testicular and splenichypoplasia, thymic hyperplasia, thrombocytopenia, aberrant cell cycle progression, and premature centromere division, MOL ENDOCR, 15(11), 2001, pp. 1870-1879
Authors:
Bousquet, C
Chesnokova, V
Kariagina, A
Ferrand, A
Melmed, S
Citation: C. Bousquet et al., cAMP neuropeptide agonists induce pituitary suppressor of cytokine signaling-3: Novel negative feedback mechanism for corticotroph cytokine action, MOL ENDOCR, 15(11), 2001, pp. 1880-1890
Authors:
Melmed, S
Citation: S. Melmed, Citation for the 2001 Robert H. Williams Distinguished Leadership Award ofthe Endocrine Society to Dr. Jesse Roth, ENDOCR REV, 22(4), 2001, pp. 554-555
Authors:
van der Lely, AJ
Hutson, RK
Trainer, PJ
Besser, GM
Barkan, AL
Katznelson, L
Klibanski, A
Herman-Bonert, V
Melmed, S
Vance, ML
Freda, PU
Stewart, PM
Friend, KE
Clemmons, DR
Johannsson, G
Stavrou, S
Cook, DM
Phillips, LS
Strasburger, CJ
Hacker, S
Zib, KA
Davis, RJ
Scarlett, JA
Thorner, M
Citation: Aj. Van Der Lely et al., Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist, LANCET, 358(9295), 2001, pp. 1754-1759
Authors:
Melmed, S
Citation: S. Melmed, The immuno-neuroendocrine interface, J CLIN INV, 108(11), 2001, pp. 1563-1566
Authors:
Melmed, S
Citation: S. Melmed, Acromegaly and cancer: Not a problem?, J CLIN END, 86(7), 2001, pp. 2929-2934
Authors:
Rubinek, T
Hadani, M
Barkai, G
Melmed, S
Shimon, I
Citation: T. Rubinek et al., Prolactin (PRL)-releasing peptide stimulates PRL secretion from human fetal pituitary cultures and growth hormone release from cultured pituitary adenomas, J CLIN END, 86(6), 2001, pp. 2826-2830
Authors:
Ishikawa, H
Heaney, AP
Yu, R
Horwitz, GA
Melmed, S
Citation: H. Ishikawa et al., Human pituitary tumor-transforming gene induces angiogenesis, J CLIN END, 86(2), 2001, pp. 867-874
Authors:
Shimon, I
Melmed, S
Citation: I. Shimon et S. Melmed, Pathogenesis and molecular biology of pituitary tumors, DIAGNOSIS AND MANAGEMENT OF PITUITARY TUMORS, 2001, pp. 71-79
Authors:
Heaney, AP
Melmed, S
Citation: Ap. Heaney et S. Melmed, New pituitary oncogenes, ENDOCR-R CA, 7(1), 2000, pp. 3-15
Authors:
Stefaneanu, L
Kovacs, K
Thapar, K
Horvath, E
Melmed, S
Greenman, Y
Citation: L. Stefaneanu et al., Octreotide effect on growth hormone and somatostatin subtype 2 receptor mRNAs of the human pituitary somatotroph adenomas, ENDOCR PATH, 11(1), 2000, pp. 41-48
Authors:
Yu, R
Ren, SG
Horwitz, GA
Wang, ZY
Melmed, S
Citation: R. Yu et al., Pituitary tumor transforming gene (PTTG) regulates placental JEG-3 cell division and survival: Evidence from live cell imaging, MOL ENDOCR, 14(8), 2000, pp. 1137-1146
Authors:
Auernhammer, CJ
Melmed, S
Citation: Cj. Auernhammer et S. Melmed, Leukemia-inhibitory factor - Neuroimmune modulator of endocrine function, ENDOCR REV, 21(3), 2000, pp. 313-345
Authors:
Heaney, AP
Singson, R
McCabe, CJ
Nelson, V
Nakashima, M
Melmed, S
Citation: Ap. Heaney et al., Expression of pituitary-tumour transforming gene in colorectal tumours, LANCET, 355(9205), 2000, pp. 716-719
Authors:
Bousquet, C
Zatelli, MC
Melmed, S
Citation: C. Bousquet et al., Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing, J CLIN INV, 106(11), 2000, pp. 1417-1425
Authors:
Maheshwari, HG
Prezant, TR
Herman-Bonert, V
Shahinian, H
Kovacs, K
Melmed, S
Citation: Hg. Maheshwari et al., Long-acting peptidomimergic control of gigantism caused by pituitary acidophilic stem cell adenoma, J CLIN END, 85(9), 2000, pp. 3409-3416
Growth hormone receptor antagonist therapy in acromegalic patients resistant to somatostatin analogs
Authors:
Herman-Bonert, VS
Zib, K
Scarlett, JA
Melmed, S
Citation: Vs. Herman-bonert et al., Growth hormone receptor antagonist therapy in acromegalic patients resistant to somatostatin analogs, J CLIN END, 85(8), 2000, pp. 2958-2961
Authors:
Giustina, A
Barkan, A
Casanueva, FF
Cavagnini, F
Frohman, L
Ho, K
Veldhuis, J
Wass, J
Von Werder, K
Melmed, S
Citation: A. Giustina et al., Criteria for cure of acromegaly: A consensus statement, J CLIN END, 85(2), 2000, pp. 526-529
Authors:
Drange, MR
Fram, NR
Herman-Bonert, V
Melmed, S
Citation: Mr. Drange et al., Pituitary tumor registry: A novel clinical resource, J CLIN END, 85(1), 2000, pp. 168-174
Authors:
Yu, R
Heaney, AP
Lu, WG
Chen, JD
Melmed, S
Citation: R. Yu et al., Pituitary tumor transforming gene causes aneuploidy and p53-dependent and p53-independent apoptosis, J BIOL CHEM, 275(47), 2000, pp. 36502-36505